Ikarian Capital, LLC - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q2 2022$1,337,000
-4.8%
830,007
-0.1%
0.24%
+31.9%
Q1 2022$1,404,000
-9.9%
830,747
+5.0%
0.18%
-20.3%
Q4 2021$1,558,000
-3.9%
790,8380.0%0.23%
+103.5%
Q3 2021$1,622,000
-15.3%
790,838
-1.2%
0.11%
-26.5%
Q2 2021$1,915,000
+19.6%
800,8110.0%0.16%
+187.0%
Q1 2021$1,601,000800,8110.05%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,593,286$5,751,0000.66%
Ikarian Capital, LLC 830,007$1,337,0000.24%
Telemetry Investments, L.L.C. 118,000$190,0000.22%
Urban Wealth Management, LLC 12,018$19,0000.06%
DLD Asset Management, LP 337,300$541,0000.04%
Phoenix Holdings Ltd. 513,597$827,0000.02%
Caption Management, LLC 140,000$225,0000.00%
HBK Sorce Advisory LLC 22,000$35,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 79,716$128,0000.00%
Total Clarity Wealth Management, Inc. 4,000$6,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders